Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew user guidance and join-related navigation items have been added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). The label formatting for Intervention/Treatment was updated, and a site revision note (Revision: v3.6.0) is shown.SummaryDifference0.5%

- Check20 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing v3.5.4. This reflects a small update to the page's version/build tag rather than changes to the study details.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, reflecting a version update on the page. This metadata change updates the page's revision number but does not modify the study content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous v3.5.2. This marks a new version of the page metadata rather than a substantive update to study details.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 on the page.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer
Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.